Closing

Do PCSK9 inhibitors improve inflammation & biomarkers versus placebo?

Mostly studied in coronary & atherosclerotic disease.

Not modeled yetTrial evidence exists, but no mechanistic model yetWithout a model there is no decisive experiment to propose. Help build it. →

Where the evidence stands

Doubtful. So far, no trial evidence yet.

NoUnsureYes
Belief
0.25 (range 0.10–0.70)
Trials for
0
Trials against
0
Inconclusive
3

Already under way

The evidence so far

Registered trials
27
With posted results
4
Published papers
0

Of 4 decided analyses: 0 favor pcsk9 inhibitors, 4 find no difference, 0 favor the comparator.

Trials

See every trial in the evidence map →